Calmangafodipir May Reduce Chemo-Induced NeuropathyCalmangafodipir May Reduce Chemo-Induced Neuropathy

In colorectal cancer patients treated with the FOLFOX regimen, calmangafodipir reduced the incidence of chemotherapy-induced peripheral neuropathy. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news